2950-2535

AJO International

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 282 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact282 DOIs
2

Attach ORCID iDs across 34 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact34 DOIs
3

Deposit reference lists for 11 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact11 DOIs

DOIs for this ISSN

Showing the top 5 of 282 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The impact of lifestyle factors on myopia development: Insig… (10.1016/j.ajoint.2024.100010)
Abstract ORCID
70.75 25
2 Ab interno minimally invasive glaucoma surgery combined with… (10.1016/j.ajoint.2024.100015)
Abstract ORCID
55.70 12
3 Needle goniotomy decreases early intraocular pressure spike… (10.1016/j.ajoint.2024.100004)
Abstract ORCID
34.95 4
4 The performance of artificial intelligence-based large langu… (10.1016/j.ajoint.2024.100070)
Abstract
33.06 20
5 Prediction of postoperative visual acuity restoration in mac… (10.1016/j.ajoint.2024.100008)
Abstract ORCID
30.10 3
6 Testing the power of Google DeepMind: Gemini versus ChatGPT… (10.1016/j.ajoint.2024.100063)
Abstract
29.40 14
7 Glaucoma in women: What do we know so far - A systematic rev… (10.1016/j.ajoint.2024.100013)
Abstract
26.03 10
8 Generative artificial intelligence for increasing accessibil… (10.1016/j.ajoint.2024.100016)
Abstract
25.00 9
9 Natural history of non-neovascular pigment epithelial detach… (10.1016/j.ajoint.2025.100100)
Abstract ORCID
23.86 2
10 Perspectives on eye care access and telemedicine-based glauc… (10.1016/j.ajoint.2025.100144)
Abstract ORCID
23.86 2
11 Posterior capsule rupture as a performance indicator in resi… (10.1016/j.ajoint.2025.100181)
Abstract ORCID
23.86 2
12 Efficient capture of dry eye data from the real world: The S… (10.1016/j.ajoint.2024.100065)
Abstract
22.58 7
13 Chat GPT 4o vs residents: French language evaluation in opht… (10.1016/j.ajoint.2025.100104)
Abstract
22.58 7
14 Assessment of intraocular pressure changes following intravi… (10.1016/j.ajoint.2024.100001)
Abstract
21.13 6
15 Hidden in plain sight: AI-driven steganography and watermark… (10.1016/j.ajoint.2024.100043)
Abstract
21.13 6
16 Studies of birth month confirm the role of education in myop… (10.1016/j.ajoint.2024.100090)
Abstract
21.13 6
17 Evaluation of ChatGPT-4 in detecting referable diabetic reti… (10.1016/j.ajoint.2025.100111)
Abstract
21.13 6
18 A global survey of visual symptoms in female carriers of cho… (10.1016/j.ajoint.2024.100002)
Abstract
19.45 5
19 Risk factors for retinal vein occlusion: Multivariate approa… (10.1016/j.ajoint.2024.100006)
Abstract
19.45 5
20 Genotype-phenotype severity correlation in a multicentric po… (10.1016/j.ajoint.2024.100029)
Abstract
19.45 5
21 Pilot study evaluating the usability of MonŒil, a ChatGPT-ba… (10.1016/j.ajoint.2024.100032)
Abstract
19.45 5
22 Artificial intelligence, adversarial attacks, and ocular war… (10.1016/j.ajoint.2024.100062)
Abstract
19.45 5
23 Early real-world experience with intravitreal Faricimab for… (10.1016/j.ajoint.2024.100074)
Abstract
19.45 5
24 Is Automated Machine Learning useful for ocular toxoplasmosi… (10.1016/j.ajoint.2024.100079)
Abstract
19.45 5
25 Visual rehabilitation in subconjunctival MIGS versus trabecu… (10.1016/j.ajoint.2025.100108)
Abstract
19.45 5
26 Short-term results with faricimab in neovascular age-related… (10.1016/j.ajoint.2024.100049)
Abstract
17.47 4
27 Optic cup morphology associated with glaucomatous damage: Fi… (10.1016/j.ajoint.2024.100053)
Abstract
17.47 4
28 3-year safety and efficacy results of PreserFlo™ Microshunt… (10.1016/j.ajoint.2024.100054)
Abstract
17.47 4
29 State of the art, advantages and drawbacks of XEN 63 gel ste… (10.1016/j.ajoint.2024.100058)
Abstract
17.47 4
30 Toxic optic neuropathy from heavy metal exposure: A comprehe… (10.1016/j.ajoint.2025.100107)
Abstract
17.47 4
31 The effects of transitioning from SITA-Standard to SITA-Fast… (10.1016/j.ajoint.2025.100116)
Abstract
17.47 4
32 Prevalence, coverage and effective coverage of refractive er… (10.1016/j.ajoint.2025.100162)
Abstract
17.47 4
33 Effectiveness of intracameral antibiotics in reducing postop… (10.1016/j.ajoint.2025.100168)
Abstract
17.47 4
34 Inflammation and increased intraocular pressure associated w… (10.1016/j.ajoint.2025.100179)
Abstract
17.47 4
35 Factors influencing contact lenses uptake among school-going… (10.1016/j.ajoint.2024.100033)
Abstract
15.05 3
36 Intravitreal cord-blood platelet-rich plasma for dry-AMD: Sa… (10.1016/j.ajoint.2024.100045)
Abstract
15.05 3
37 Teprotumumab-associated aural fullness and ageusia: A case r… (10.1016/j.ajoint.2024.100047)
Abstract
15.05 3
38 Heavy silicone oil tamponade in retinal detachment surgery:… (10.1016/j.ajoint.2024.100055)
Abstract
15.05 3
39 Advanced diagnostic approaches for SHAPU: Metagenomic sequen… (10.1016/j.ajoint.2024.100056)
Abstract
15.05 3
40 Gender analysis of ophthalmology fellowship program director… (10.1016/j.ajoint.2024.100057)
Abstract ORCID
15.05 1
41 Accessibility of United States ophthalmology hospital webpag… (10.1016/j.ajoint.2024.100059)
Abstract
15.05 3
42 Factors affecting quality of life in patients with neovascul… (10.1016/j.ajoint.2024.100066)
Abstract
15.05 3
43 Ophthalmologic care for Indigenous Canadians (10.1016/j.ajoint.2024.100067)
Abstract
15.05 3
44 Comparative analysis of modulation transfer function in vari… (10.1016/j.ajoint.2024.100069)
Abstract
15.05 3
45 Ophthalmic manifestations and complications following electr… (10.1016/j.ajoint.2024.100089)
Abstract
15.05 3
46 Psychological empowerment after presbyopia correction: A nar… (10.1016/j.ajoint.2025.100098)
Abstract
15.05 3
47 Accelerating visual field loss with age: A statistical appro… (10.1016/j.ajoint.2025.100117)
Abstract ORCID
15.05 1
48 Evidence for Whom? A Systematic Review of Eligibility Criter… (10.1016/j.ajoint.2025.100124)
Abstract
15.05 3
49 Age outweighs race in survival of sebaceous gland carcinoma… (10.1016/j.ajoint.2025.100129)
Abstract
15.05 3
50 The Danish Ophthalmological Society guidelines for screening… (10.1016/j.ajoint.2025.100141)
Abstract
15.05 3